A Chicago-based pharmaceutical giant recently urged a federal court to block Colorado’s contract pharmacy access law—marking the first drug manufacturer [...] …
Category: Federal
A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...] …
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...] …
A key health policy staffer for U.S. Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Bill Cassidy (R-La.) recently [...] …
Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...] …
Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...] …
A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
340B stakeholders and attorneys offered mixed initial reactions this week to President Donald Trump’s proposal to move the 340B program [...] …